McNeill J R, Wilcox W C, Regnault R
Can J Physiol Pharmacol. 1976 Jun;54(3):373-80. doi: 10.1139/y76-052.
Intravenous administration of furosemide (2 mg/kg) caused intestinal vasoconstriction in various groups of pentobarbital-anesthetized cats. (Sar1, Ala 8)-angiotensin II, a specific competitive antagonist of angiotensin II, was infused 60 min after administration of furosemide, a time when the intestinal vasoconstrictor response to the diuretic was maximal or near maximal. In hypophysectomized animals, infusion of the antagonist abolished the intestinal vasoconstriction and caused a significant fall in arterial pressure even when the intestinal nerves and adrenal glands remained intact. In contrast, the antagonist had little effect when the pituitary gland remained intact. The results suggest that endogenous angiotensin and vasopressin are overlapping mechanisms which constrict the intestinal resistance vessels and support arterial pressure following furosemide-induced volume depletion. In the absence of one control system, the other compensates to maintain the responses.
静脉注射呋塞米(2毫克/千克)可导致戊巴比妥麻醉的不同组猫出现肠道血管收缩。在注射呋塞米60分钟后(此时肠道对利尿剂的血管收缩反应达到最大或接近最大),输注(Sar1,Ala 8)-血管紧张素II(一种血管紧张素II的特异性竞争性拮抗剂)。在垂体切除的动物中,即使肠道神经和肾上腺保持完整,输注拮抗剂也能消除肠道血管收缩并导致动脉压显著下降。相比之下,当垂体保持完整时,拮抗剂几乎没有作用。结果表明,内源性血管紧张素和血管加压素是重叠机制,在呋塞米诱导的容量耗竭后,它们会使肠道阻力血管收缩并维持动脉压。在缺乏一个控制系统的情况下,另一个系统会进行补偿以维持反应。